Suppr超能文献

应对儿科给药挑战:口腔速崩片对婴幼儿的潜力

Meeting Challenges of Pediatric Drug Delivery: The Potential of Orally Fast Disintegrating Tablets for Infants and Children.

作者信息

Golhen Klervi, Buettcher Michael, Kost Jonas, Huwyler Jörg, Pfister Marc

机构信息

Pediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel (UKBB), University of Basel, 4056 Basel, Switzerland.

Paediatric Infectious Diseases Unit, Paediatric Department, Children's Hospital Lucerne, Cantonal Hospital Lucerne, 6000 Luzern, Switzerland.

出版信息

Pharmaceutics. 2023 Mar 23;15(4):1033. doi: 10.3390/pharmaceutics15041033.

Abstract

A majority of therapeutics are not available as suitable dosage forms for administration to pediatric patients. The first part of this review provides an overview of clinical and technological challenges and opportunities in the development of child-friendly dosage forms such as taste masking, tablet size, flexibility of dose administration, excipient safety and acceptability. In this context, developmental pharmacology, rapid onset of action in pediatric emergency situations, regulatory and socioeconomic aspects are also reviewed and illustrated with clinical case studies. The second part of this work discusses the example of Orally Dispersible Tablets (ODTs) as a child-friendly drug delivery strategy. Inorganic particulate drug carriers can thereby be used as multifunctional excipients offering a potential solution to address unique medical needs in infants and children while maintaining a favorable excipient safety and acceptability profile in these vulnerable patient populations.

摘要

大多数治疗药物没有适合给儿科患者使用的剂型。本综述的第一部分概述了开发儿童友好型剂型时面临的临床和技术挑战与机遇,如掩味、片剂尺寸、给药剂量灵活性、辅料安全性和可接受性。在此背景下,还通过临床案例研究对发育药理学、儿科紧急情况下的快速起效、监管和社会经济方面进行了综述和说明。本研究的第二部分讨论了口腔崩解片(ODT)作为一种儿童友好型药物递送策略的实例。无机颗粒药物载体因此可作为多功能辅料,为满足婴幼儿和儿童独特的医疗需求提供潜在解决方案,同时在这些脆弱的患者群体中保持良好的辅料安全性和可接受性。

相似文献

2
Orally disintegrating tablets and orally disintegrating mini tablets - novel dosage forms for pediatric use.
Pharm Dev Technol. 2019 Sep;24(7):902-914. doi: 10.1080/10837450.2019.1615090.
3
Development of Oral Flexible Tablet (OFT) Formulation for Pediatric and Geriatric Patients: a Novel Age-Appropriate Formulation Platform.
AAPS PharmSciTech. 2017 Aug;18(6):1972-1986. doi: 10.1208/s12249-016-0666-0. Epub 2016 Dec 5.
4
Orodispersible tablets for pediatric drug delivery: current challenges and recent advances.
Expert Opin Drug Deliv. 2021 Dec;18(12):1873-1890. doi: 10.1080/17425247.2021.2011856. Epub 2021 Dec 3.
5
Orally disintegrating films and mini-tablets-innovative dosage forms of choice for pediatric use.
AAPS PharmSciTech. 2015 Apr;16(2):234-41. doi: 10.1208/s12249-015-0313-1. Epub 2015 Mar 5.
6
Challenges and emerging solutions in the development of compressed orally disintegrating tablets.
Expert Opin Drug Discov. 2014 Oct;9(10):1109-20. doi: 10.1517/17460441.2014.941802. Epub 2014 Jul 21.
7
Pediatric Oral Formulations: An Updated Review of Commercially Available Pediatric Oral Formulations Since 2007.
J Pharm Sci. 2019 Apr;108(4):1335-1365. doi: 10.1016/j.xphs.2018.11.013. Epub 2018 Nov 14.
9
Development and optimization of taste-masked orally disintegrating tablets (ODTs) of clindamycin hydrochloride.
Drug Dev Ind Pharm. 2015;41(7):1156-64. doi: 10.3109/03639045.2014.935392. Epub 2014 Jul 7.
10
Drug Formulations: Standards and Novel Strategies for Drug Administration in Pediatrics.
J Clin Pharmacol. 2018 Oct;58 Suppl 10:S26-S35. doi: 10.1002/jcph.1138.

本文引用的文献

1
Oromucosal products - Market landscape and innovative technologies: A review.
J Control Release. 2022 Aug;348:305-320. doi: 10.1016/j.jconrel.2022.05.053. Epub 2022 Jun 8.
2
Opportunities for enteral drug delivery for neonates, infants, and toddlers: a critical exploration.
Expert Opin Drug Deliv. 2022 May;19(5):475-519. doi: 10.1080/17425247.2022.2064449. Epub 2022 May 29.
4
Drug-handling problems and expectations of the ideal pediatric drug-reported by children and their parents.
Eur J Pediatr. 2022 May;181(5):2161-2171. doi: 10.1007/s00431-022-04419-6. Epub 2022 Feb 23.
5
Medication Errors in Pediatrics: Proposals to Improve the Quality and Safety of Care Through Clinical Risk Management.
Front Med (Lausanne). 2022 Jan 14;8:814100. doi: 10.3389/fmed.2021.814100. eCollection 2021.
6
Review of paediatric gastrointestinal physiology relevant to the absorption of orally administered medicines.
Adv Drug Deliv Rev. 2022 Feb;181:114084. doi: 10.1016/j.addr.2021.114084. Epub 2021 Dec 17.
7
Orodispersible tablets for pediatric drug delivery: current challenges and recent advances.
Expert Opin Drug Deliv. 2021 Dec;18(12):1873-1890. doi: 10.1080/17425247.2021.2011856. Epub 2021 Dec 3.
8
High Acceptability of an Orally Dispersible Tablet Formulation by Children.
Children (Basel). 2021 Mar 5;8(3):194. doi: 10.3390/children8030194.
9
Recent Formulation Advances and Therapeutic Usefulness of Orally Disintegrating Tablets (ODTs).
Pharmacy (Basel). 2020 Oct 10;8(4):186. doi: 10.3390/pharmacy8040186.
10
Predicting oral disintegrating tablet formulations by neural network techniques.
Asian J Pharm Sci. 2018 Jul;13(4):336-342. doi: 10.1016/j.ajps.2018.01.003. Epub 2018 Feb 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验